Sign in

CIK 0001708599

  • Non-accelerated filer
  • Smaller reporting company

Serina Therapeutics, Inc.

Sign in to watch
Ticker
SER
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
AL
Entity type
Operating
EIN
821436829
Phone
+1 256-327-9630
Business address
601 GENOME WAY, SUITE 2001, HUNTSVILLE, AL, 35806
Former names
AgeX Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-17 Venkatesan Jay Director Conversion +224,152 $2.25 $504K 231,705
2026-06-17 Venkatesan Jay Director Grant or award · Stock Option (right to buy) +15,250 15,250
2026-06-17 Venkatesan Jay Director Conversion · Series A Convertible Preferred Stock −96,525 $2.25 $217K 0
2026-05-22 Venkatesan Jay Director Purchase +589 $1.78 $1K 589
2026-03-31 Venkatesan Jay Director Grant or award +7,553 $1.94 $15K 7,553
2025-11-07 Venkatesan Jay Director Grant or award · Stock Option (right to buy) +10,000 10,000
2025-04-08 Venkatesan Jay Director Grant or award · Series A Convertible Preferred Stock +96,525 $5.18 $500K 96,525
2025-02-12 Venkatesan Jay Director Grant or award · Stock Option (right to buy) +40,000 40,000

Page 1 of 1 · 8 trades